Racura Oncology LtdASX: RAC

First Patient Safely Combine Dosed in Phase 1 RC220 Trial

Jun 19, 2025 at 3:17 AM UTC · Issued by Racura Oncology Ltd

Race Oncology Ltd has released a press release.

View Attachment